AAVantgarde Bio is a Biotech company based in Milano, Italy. It has raised $202M in total funding. Latest round: Series B.
AAVantgarde Bio funding overview
AAVantgarde Bio is a Biotech company based in Milano, Italy. AAVantgarde Bio has raised $202M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B. Investors on record include Atlas Venture, Forbion, Sofinnova Partners, Telethon Fund, Longwood Fund. 5 distinct backers are named across the disclosed rounds.
AAVantgarde Bio at a glance
Total raised
$202M
Latest round
Series B
Industry
Biotech
Headquarters
Milano, Italy
Notable investors
Atlas Venture, Forbion, Sofinnova Partners, Telethon Fund, Longwood Fund
Frequently asked about AAVantgarde Bio funding
How much has AAVantgarde Bio raised?
AAVantgarde Bio has raised $202M in total disclosed funding across the rounds on record.
Who has invested in AAVantgarde Bio?
Atlas Venture, Forbion, Sofinnova Partners, Telethon Fund, Longwood Fund are named among the investors backing AAVantgarde Bio.
What was the latest AAVantgarde Bio funding round?
The most recent disclosed round is a Series B.
Where is AAVantgarde Bio based?
AAVantgarde Bio is based in Milano, Italy.
What sector does AAVantgarde Bio operate in?
AAVantgarde Bio is tracked under Biotech from Milano, Italy, with $202M in disclosed funding.
Totals shown for AAVantgarde Bio aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Milano and the investors behind them below.
